ONLINE TDM Phenytoin 08445567190Recalls & reported problems
Roche Diagnostics GmbH · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 07613336157787), received between Oct 12, 2023 and Feb 26, 2026 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Incorrect, Inadequate or Imprecise Result or Readings” (1 report).
2 other recalls cover devices cleared under the same FDA submission (K030428, K230161); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Incorrect, Inadequate or Imprecise Result or Readings1
- Low Readings1
- Low Test Results1
- Non Reproducible Results1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionFeb 26, 2026Incorrect, Inadequate or Imprecise Result or Readings; Non Reproducible Results
THE INITIAL REPORTER STATED THEY RECEIVED DISCREPANT RESULTS FOR 12 PATIENT SAMPLES TESTED WITH ONLINE TDM PHENYTOIN - FREE PHENYTOIN APPLICATION ON A COBAS C 503 ANALYTICAL UNIT. PLEASE REFER TO THE ATTACHMENT FOR ALL PATIENT DATA.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24455671 ↗MalfunctionOct 12, 2023Low Test Results; Low Readings; Low Test Results; Low Readings
THE INITIAL REPORTER RECEIVED QUESTIONABLE PHNY2 PHENYTOIN RESULTS FROM ONE PATIENT SAMPLE TESTED ON THE COBAS PURE C 303 ANALYTICAL UNIT. THE DOCTOR CONTESTED THE INITIAL RESULT BECAUSE A PHENYTOIN DOSE WAS GIVEN TO THE PATIENT, PROMPTING THE RERUN OF THE INITIAL PATIENT SAMPLE. A NEW SAMPLE WAS ALSO COLLECTED FROM THE PATIENT. THE INITIAL RESULT OF THE INITIAL SAMPLE WAS 0.000000 UMOL/L WITH A DATA FLAG. THE FIRST REPEAT RESULT OF THE INITIAL SAMPLE WAS 3.06 UMOL/L WITH A DATA FLAG. THE SECOND REPEAT RESULT OF THE INITIAL SAMPLE WAS 3.21 UMOL/L WITH A DATA FLAG. THE INITIAL RESULT OF THE NEW SAMPLE WAS 0.0000 UMOL/L WITH A DATA FLAG. THE REPEAT RESULT OF THE NEW SAMPLE WITH DILUTION WAS 0.0000 UMOL/L WITH A DATA FLAG.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17919236 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K030428, K230161. One submission often covers many models, so check the product and lot details in each record.
- Z-1062-04 · Jun 18, 2004 · TerminatedRoche/Hitachi brand ONLINE TDM Phenytoin; Contents of kit: 1- 2 x 17 ml phenytoin conjugate and 2- 2 x 18 ml anti-phenytoin antibody (mouse monoclonal); latex microparticle. Pro
- Z-1063-04 · Jun 18, 2004 · TerminatedRoche/Hitachi brand ONLINE TDM Phenytoin; Contents of kit: 1- 1 x 37 ml phenytoin conjugate and 2- 1 x 38 ml anti-phenytoin antibody (mouse monoclonal); latex microparticle. Prod
Other ENZYME IMMUNOASSAY, DIPHENYLHYDANTOIN devices
- VITROS 8298671Ortho-Clinical Diagnostics, Inc. · ENZYME IMMUNOASSAY, DIPHENYLHYDANTOIN1 recall67 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page